Skip to main content
Log in

Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The in vitro binding of the enantiomers of hydroxychloroquine and its three major metabolites in pooled plasma obtained from four healthy volunteers and the binding of the enantiomers of hydroxychloroquine to purified plasma proteins has been investigated.

The plasma protein binding of hydroxychloroquine was found to be stereoselective. The (S)-enantiomer of hydroxychloroquine was 64% bound in plasma, while (R)-hydroxychloroquine was 37% bound. Fifty % of (S)-hydroxychloroquine was bound to a 40 g·l−1 solution of human serum albumin, while only 29% of the (R)-enantiomer was bound. The enantioselectivity of hydroxychloroquine binding was reversed in a 0.7 g·l−1 solution of α1-acid glycoprotein with (R)-hydroxychloroquine being bound to a greater extent than its optical antipode (41% versus 29%). The enantiomers of the metabolites of hydroxychloroquine were bound to a similar extent to plasma and purified plasma proteins.

Binding of hydroxychloroquine to plasma and purified proteins was found to be linear over the racemic concentration range of 50 to 1000 ng·ml−1 and hydroxychloroquine metabolite binding to plasma was linear over the range 25 to 500 ng·ml−1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Geary TG, Akood MA, Jensen JB (1983) Characteristics of chloroquine binding to glass and plastic. Am J Trop Med Hyg 32: 19–23

    Google Scholar 

  • Gibaldi DA, Perrier D (1982) Pharmacokinetics, 2nd edn. Dekker, New York

    Google Scholar 

  • Levy RH, Boddy AV (1991) Stereoselectivity in pharmacokinetics: a general theory. Pharm Res 8: 551–555

    Google Scholar 

  • McLachlan AJ, Tett SE, Cutler DJ (1991) High-performance liquid chromatographic separation of the enantiomers of hydroxychloroquine and its major metabolites in biological fluids using α1-acid glycoprotein stationary phase. J Chromatogr 570: 119–127

    Google Scholar 

  • Miller DR, Khalil SRW, Nygan GA (1991) Steady-state pharmacokinetics of hydroxychloroquine in rheumatoid arthritis patients. Ann Pharmacother 25: 1302–1305

    Google Scholar 

  • Ofori-Adjei D, Ericsson O, Lindstrom B, Sjöqvist F (1986) Protein binding of chloroquine enantiomers and desethylchloroquine. Br J Clin Pharmacol 22: 356–358

    Google Scholar 

  • Piafsky KM, Borgä O (1977) Protein binding of basic drugs. II. Importance of α1-acid glycoprotein for individual variation. Clin Pharmacol Ther 22: 545–549

    Google Scholar 

  • Piafsky KM, Borgä O, Odar-Cederloe I, Johnsson C, Sjöqvist F (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma α1-acid glycoprotein. New Eng J Med 299: 1435–1439

    Google Scholar 

  • Piafsky KM (1980) Disease-induced changes in the plasma binding of basic drugs. Clin Pharmacokinet 5: 246–262

    Google Scholar 

  • Routledge PA (1986) The plasma protein binding of basic drugs. Br J Clin Pharmacol 22: 499–506

    Google Scholar 

  • Skeith KJ, Jamali F (1991) Clinical pharmacokinetics of drugs used in juvenile arthritis. Clin Pharmacokinet 21: 129–149

    Google Scholar 

  • Tett SE, Cutler DJ, Day RO, Brown KF (1988) Dose-ranging study of the pharmacokinetics of hydroxychloroquine following intravenous administration to healthy volunteers. Br J Clin Pharmacol 26: 303–313

    Google Scholar 

  • Tett SE, Cutler DJ, Day RO (1990a) Hydroxychloroquine concentrations and clinical effects in rheumatoid arthritis patients. Eur J Pharmacol 183: 1035

    Google Scholar 

  • Tett SE, Cutler DJ, Day RO (1990b) Antimalarials in rheumatic diseases. In: Brooks PM (ed) Bailliere's clinical rheumatology. Slowacting antirheumatic drugs and immunosuppressives. Baillière, Tindall, Sydney, pp 467–489

    Google Scholar 

  • Tucker GT, Lennard MS (1990) Enantiomer specific pharmacokinetics. Pharmac Ther 45: 309–329

    Google Scholar 

  • Walker O, Birkett DJ, Alván G, Gustafsson LL, Sjöqvist F (1983) Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol 15: 375–377

    Google Scholar 

  • Williams KM, Lee EJD (1985) Importance of drug enantiomers in clinical pharmacology. Drugs 30: 333–354

    Google Scholar 

  • Yahya AM, McElnay JC, D'Arcy PF (1986) Investigation of chloroquine binding to plastic materials. Int J Pharm 34: 137–143

    Google Scholar 

  • Zini R, Riant P, Barré J, Tillement J-P (1990) Disease induced variations in plasma protein levels: implications for drug dosage regimens (I). Clin Pharmacokinet 19: 147–159

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLachlan, A.J., Cutler, D.J. & Tett, S.E. Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites. Eur J Clin Pharmacol 44, 481–484 (1993). https://doi.org/10.1007/BF00315548

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315548

Key words

Navigation